Cargando…

Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies

Detalles Bibliográficos
Autores principales: Mahler, Michael, Kim, Grace, Roup, Fabrece, Bentow, Chelsea, Fabien, Nicole, Goncalves, David, Palterer, Boaz, Fritzler, Marvin J., Villalta, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496588/
https://www.ncbi.nlm.nih.gov/pubmed/34118009
http://dx.doi.org/10.1007/s12026-021-09206-3
_version_ 1784579783494991872
author Mahler, Michael
Kim, Grace
Roup, Fabrece
Bentow, Chelsea
Fabien, Nicole
Goncalves, David
Palterer, Boaz
Fritzler, Marvin J.
Villalta, Danilo
author_facet Mahler, Michael
Kim, Grace
Roup, Fabrece
Bentow, Chelsea
Fabien, Nicole
Goncalves, David
Palterer, Boaz
Fritzler, Marvin J.
Villalta, Danilo
author_sort Mahler, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-8496588
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-84965882021-10-19 Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies Mahler, Michael Kim, Grace Roup, Fabrece Bentow, Chelsea Fabien, Nicole Goncalves, David Palterer, Boaz Fritzler, Marvin J. Villalta, Danilo Immunol Res Correction Springer US 2021-06-12 2021 /pmc/articles/PMC8496588/ /pubmed/34118009 http://dx.doi.org/10.1007/s12026-021-09206-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Mahler, Michael
Kim, Grace
Roup, Fabrece
Bentow, Chelsea
Fabien, Nicole
Goncalves, David
Palterer, Boaz
Fritzler, Marvin J.
Villalta, Danilo
Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title_full Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title_fullStr Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title_full_unstemmed Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title_short Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
title_sort correction to: evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496588/
https://www.ncbi.nlm.nih.gov/pubmed/34118009
http://dx.doi.org/10.1007/s12026-021-09206-3
work_keys_str_mv AT mahlermichael correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT kimgrace correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT roupfabrece correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT bentowchelsea correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT fabiennicole correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT goncalvesdavid correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT paltererboaz correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT fritzlermarvinj correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies
AT villaltadanilo correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies